Long-Term Safety of Anti-TNF Adalimumab in HBc Antibody-Positive Psoriatic Arthritis Patients: A Retrospective Case Series of 8 Patients

DOI: 10.1155/2013/410521

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text